1-(tert-Butoxycarbonyl)indoline-6-carboxylic acid

Catalog No. :
ACZDJU695
CAS No. :
208772-41-2
Molecular Formula :
C14H17NO4
Molecular Weight :
263.29

IUPAC Name:1-(tert-butoxycarbonyl)indoline-6-carboxylic acid

1-(tert-Butoxycarbonyl)indoline-6-carboxylic acid structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg95%$63.00Login to see priceIn stockInquiry
250mg95%$92.00Login to see priceIn stockInquiry
1g95%$239.00Login to see priceIn stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name1-(tert-Butoxycarbonyl)indoline-6-carboxylic acid
IUPAC Name1-(tert-butoxycarbonyl)indoline-6-carboxylic acid
MDL No.MFCD09878909
Molecular FormulaC14H17NO4
Molecular Weight263.29
SMILESO=C(C1=CC2=C(C=C1)CCN2C(OC(C)(C)C)=O)O
InChI KeyQAODAHHBCGSYTN-UHFFFAOYSA-N
Synonym1H-INDOLE-1,6-DICARBOXYLIC ACID,2,3-DIHYDRO-,1-(1,1-DIMETHYLETHYL)ESTER;1-(tert-Butoxycarbonyl)indoline-6-carboxylic acid;2,3-Dihydro-indole-1,6-dicarboxylic acid 1-tert-butyl ester;1-(tert-Butoxycarbonyl)indoline-6-carboxylic acid - [B93915]
CAS No.208772-41-2
PubChem CID18354849

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H315-H319
Precautionary Statement(s)
P264-P280-P302+P352-P305+P351+P338-P332+P313-P337+P313-P362

Synthetic Route by SureRoute

1. ACZDJU695 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACHJYW935 route compound structure diagram
    ACHJYW9351220039-51-9 In Stock
  2. Then
  3. ACZDJU695 route product structure diagram
    ACZDJU695208772-41-2 In Stock
Inquiry

2. ACZDJU695 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACEHYJ164 route compound structure diagram
    ACEHYJ16415861-37-7 In Stock
  4. Then
  5. ACZDJU695 route product structure diagram
    ACZDJU695208772-41-2 In Stock
Inquiry

Comments (0)